Hypermethylation of the UCHL1 promoter leads to low UCHL1 expression, and promotes cell proliferation by regulating the stability of p53 and MDM2 in hepatocellular cancer (HCC) and NPC [7,8]. This evidence concerns the gene TP53 and nasopharyngeal carcinoma.